The findings indicated that certain proteins such as Lumbricin, Chemoattractive glycoprotein ES20, and Lumbrokinase-7T1 demonstrated activity comparable to standard antagonists in regulating SOCS2 function, suggesting their candidacy for therapeutic applications in cardiovascular diseases. Here, SOCS2 is linked to cardiovascular disorder.